Skip to main content

Original Research

Sterility Duration of Single-Use Vials for Antineoplastic Agents or Monoclonal Antibodies Extended with a Closed-System Transfer Device

Major Rosalynda Uy, PharmD, BCPS; Michael S. Edwards, PharmD, MBA, BCOP, FASHP; Dominic A. Solimando, Jr, MA, BCOP, FAPhA, FASHP

Comparing Outcomes in Patients with Recurrent or Refractory Ovarian Cancer Managed with 1 of 2 Versions of Pegylated Liposomal Doxorubicin at an Academic Medical Center

Lindsey B. Amerine, PharmD, MS, BCPS; Eric Shen, PharmD; Michelle Gardiner, PharmD, BCOP, CPP

Role of Pharmacist Intervention in the Safe Administration of Anti-CD20 Monoclonal Antibodies

Hayley Ann Hodgson, PharmD; Arpita S. Gandhi, PharmD, BCOP; Stephen Michael Clark, PharmD, BCOP

Retrospective Review of the Use of Oral Chemotherapy Drugs for Patients with Metastatic Renal-Cell Carcinoma

Comparing Grade 4 Neutropenia Associated with Pegfilgrastim Administered via the Onpro Device versus Manual Injection with a Prefilled Syringe

Assessing Basic Cytotoxic Drug Levels in Hospital Pharmacies and the Efficacy of a Closed-System Drug-Transfer Device to Reduce Contamination

Evaluation of the Role of Clinical Pharmacists in the Review and Approval of Off-Label Oncology Treatment Requests

Pharmacist-Delivered Tobacco Intervention Program in an Ambulatory Oncology Clinic: A Pilot Study

Impact of Pharmacist-Driven Educational Intervention on Documentation of Bowel Function Assessment in Patients with Cancer Who Are Using Opioids

Microbial Growth of Single-Dose Antineoplastic Drug Vials at 28 Days

Page 15 of 19
Results 141 - 150 of 189